Agonistes du récepteur du GLP-1 en une injection hebdomadaire : quelles perspectives pour le patient diabétique de type 2 ?

This article discusses once-weekly GLP-1RA place, in agreement with current guidelines as part of bitherapy instituted precociously when metformin monotherapy failed, and underlines the importance of a patient-centered approach needed to favor the patient's implication in the decisions on his/her chronic disease treatment.